bioRxiv Science⌕ Search

Biology subjects

Graus, M.

Publications and source records attributed to Graus, M..

2 recordsLinked to original sources

Piezo1 couples fluid shear stress to adaptive genome dynamics by integrating cytoplasmic-nuclear mechanotransduction

Fluid shear stress (FSS) regulates endothelial morphology and function through flow-responsive gene expression programs. Yet, how mechanical forces are transmitted across cytoplasmic and nuclear compartments to regulate genome adaptive response remains unclear. Here, we show that FSS induces rapid nuclear remodeling characterized by nuclear compaction and apical nuclear indentations. These changes are driven by reorganization of perinuclear actin and microtubule cytoskeleton into apical linear cytoskeletal cables that constrain the nuclear surface. Concurrently, the mechanosensitive ion channel Piezo1 redistributes from the plasma membrane to these perinuclear deformations. Quantitative molecular imaging under flow reveals a transient adaptive cell state characterized by chromatin reorganization and epigenetic remodeling, accompanied by altered mobility of the flow-responsive transcription factor KLF2. Pharmacological inhibition of Piezo1 abolishes FSS-induced nuclear deformation and uncouples chromatin reorganization from KLF2 dynamic changes. Together, these findings reveal that endothelial mechanotransduction exploits physical principles of nuclear organization to regulate transcription factor behavior and adaptive genome responses across biological scales.

Cell Biology↗

An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma

Infantile hemangioma (IH) is the most common tumor in children and a paradigm for pathological vasculogenesis, angiogenesis and regression. Propranolol is the mainstay of treatment for IH. It inhibits hemangioma vessel formation via a {beta}-adrenergic receptor independent off-target effect of its R(+) enantiomer on the endothelial specific transcription factor sex-determining region Y (SRY) box transcription factor 18 (SOX18). Transcriptomic profiling of patient-derived hemangioma stem cells uncovered the mevalonate pathway (MVP) as a target of R(+) propranolol. Loss of SOX18 function confirmed R(+) propranolol mode of action on the MVP. Functional validation in preclinical IH models revealed that statins - targeting the MVP - are potent inhibitors of hemangioma vessel formation. We propose a novel SOX18-MVP-axis as a central regulator of IH pathogenesis and suggest statin repurposing to treat IH. Our findings reveal novel pleiotropic effects of beta-blockers and statins acting on the SOX18-MVP axis to disable an endothelial specific program in IH, which may impact other scenarios involving pathological vasculogenesis and angiogenesis. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/577829v2_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@f02b2corg.highwire.dtl.DTLVardef@1a2790forg.highwire.dtl.DTLVardef@1ba0318org.highwire.dtl.DTLVardef@1213522_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗